470 related articles for article (PubMed ID: 25568448)
41. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427
[TBL] [Abstract][Full Text] [Related]
42. Role of brain-derived neurotrophic factor in the molecular neurobiology of major depressive disorder.
Zhang Y; Shi J; Li J; Liu R; Yu Y; Xu Y
Transl Perioper Pain Med; 2017; 4(1):20-30. PubMed ID: 31595217
[TBL] [Abstract][Full Text] [Related]
43. Antidepressant action: to the nucleus and beyond.
Malberg JE; Blendy JA
Trends Pharmacol Sci; 2005 Dec; 26(12):631-8. PubMed ID: 16246434
[TBL] [Abstract][Full Text] [Related]
44. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brain-derived neurotrophic factor.
Liu CY; Jiang XX; Zhu YH; Wei DN
Neuroscience; 2012 Oct; 223():219-24. PubMed ID: 22890078
[TBL] [Abstract][Full Text] [Related]
45. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
Paoli C; Misztak P; Mazzini G; Musazzi L
Curr Neuropharmacol; 2022 Nov; 20(12):2267-2291. PubMed ID: 35105292
[TBL] [Abstract][Full Text] [Related]
46. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury.
Onishchenko N; Karpova N; Sabri F; Castrén E; Ceccatelli S
J Neurochem; 2008 Aug; 106(3):1378-87. PubMed ID: 18485098
[TBL] [Abstract][Full Text] [Related]
47. [Stress reactivity and stress-resilience in the pathogenesis of depressive disorders: involvement of epigenetic mechanisms].
Grigoryan GA; Gulyaeva NV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2015; 65(1):19-32. PubMed ID: 25966571
[TBL] [Abstract][Full Text] [Related]
48. [Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level].
Shen X; Qian M; Yuan Y; Sun J; Zhong H; Yang J; Lin M; Li L; Guan T; Shen Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):196-200. PubMed ID: 24711031
[TBL] [Abstract][Full Text] [Related]
49. [Epigenetic mechanism of depression].
Morinobu S; Fuchikami M; Yamawaki Y; Yamamoto S; Kurata A; Yamawaki S
Seishin Shinkeigaku Zasshi; 2010; 112(10):986-91. PubMed ID: 21179661
[TBL] [Abstract][Full Text] [Related]
50. Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.
Rana T; Behl T; Sehgal A; Srivastava P; Bungau S
J Mol Neurosci; 2021 Oct; 71(10):2008-2021. PubMed ID: 33230708
[TBL] [Abstract][Full Text] [Related]
51. Burst-firing patterns in the prefrontal cortex underlying the neuronal mechanisms of depression probed by antidepressants.
Guo F; Zhang Q; Zhang B; Fu Z; Wu B; Huang C; Li Y
Eur J Neurosci; 2014 Nov; 40(10):3538-47. PubMed ID: 25209309
[TBL] [Abstract][Full Text] [Related]
52. Gene × environment interactions in the prediction of response to antidepressant treatment.
Klengel T; Binder EB
Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
[TBL] [Abstract][Full Text] [Related]
53. Using a cognitive endophenotype to identify risk genes for depression.
Haeffel GJ; Eastman M; Grigorenko EL
Neurosci Lett; 2012 Feb; 510(1):10-3. PubMed ID: 22240101
[TBL] [Abstract][Full Text] [Related]
54. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression.
Dudek KA; Dion-Albert L; Lebel M; LeClair K; Labrecque S; Tuck E; Ferrer Perez C; Golden SA; Tamminga C; Turecki G; Mechawar N; Russo SJ; Menard C
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3326-3336. PubMed ID: 31974313
[TBL] [Abstract][Full Text] [Related]
55. [The neurotrophic hypothesis of depression].
Bus BA; Molendijk ML
Tijdschr Psychiatr; 2016; 58(3):215-22. PubMed ID: 26979853
[TBL] [Abstract][Full Text] [Related]
56. Type II pyrethroid deltamethrin produces antidepressant-like effects in mice.
Takasaki I; Oose K; Otaki Y; Ihara D; Fukuchi M; Tabuchi A; Tsuneki H; Tabuchi Y; Kondo T; Saitoh A; Yamada M; Tsuda M
Behav Brain Res; 2013 Nov; 257():182-8. PubMed ID: 24079995
[TBL] [Abstract][Full Text] [Related]
57. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.
Schumacher J; Jamra RA; Becker T; Ohlraun S; Klopp N; Binder EB; Schulze TG; Deschner M; Schmäl C; Höfels S; Zobel A; Illig T; Propping P; Holsboer F; Rietschel M; Nöthen MM; Cichon S
Biol Psychiatry; 2005 Aug; 58(4):307-14. PubMed ID: 16005437
[TBL] [Abstract][Full Text] [Related]
58. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.
Tsankova NM; Berton O; Renthal W; Kumar A; Neve RL; Nestler EJ
Nat Neurosci; 2006 Apr; 9(4):519-25. PubMed ID: 16501568
[TBL] [Abstract][Full Text] [Related]
59. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
60. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
Tsuji M; Miyagawa K; Takeuchi T; Takeda H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
